A股異動丨九鼎投資連續第二日漲停 新證券法全面推行註冊制
格隆匯12月31日丨九鼎投資(600053.SH)連續第二日漲停,報25.43元,總市值110億元。12月28日,第十三屆全國人大常委會第十五次會議審議通過了修訂後的《中華人民共和國證券法》,將於2020年3月1日起施行。新證券法明確全面推行證券發行註冊制度。在總結上海證券交易所設立科創板並試點註冊制的經驗基礎上,新證券法按照全面推行註冊制的基本定位,對證券發行制度做了系統的修改完善。利好創投股。九鼎投資的主營業務之一為私募股權投資管理業務、主營業務之二為房地產開發與經營。2015年11月公司9.0986億元購買昆吾九鼎100%股權,標的資產為專業私募股權投資管理機構,主營業務是私募股權投資管理(PE)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.